13 analysts have expressed a variety of opinions on Immunocore Hldgs (NASDAQ:IMCR) over the past quarter, offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 10 | 2 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 7 | 0 | 0 | 0 | 0 |
| 3M Ago | 3 | 1 | 1 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $85.46, a high estimate of $100.00, and a low estimate of $66.00. Highlighting a 0.84% decrease, the current average has fallen from the previous average price target of $86.18.
Analyzing Analyst Ratings: A Detailed Breakdown
The standing of...
ログインすると全部閲覧できます。
ログイン